- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01847833
Advanced MRI Applications Development
March 22, 2018 updated by: Elizabeth R. Gerstner, MD, Massachusetts General Hospital
The goals of this study are to:
- To improve upon and develop new innovative magnetic resonance imaging techniques that refine image quality and enhance performance. Improvements in these areas will have positive implications for medical diagnosis and treatment.
- To correlate MRI images with underlying disease pathophysiology in order to ensure that imaging accurately reflects the disease process.
Study Overview
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elizabeth Gerstner
- Phone Number: 617-724-8770
Study Contact Backup
- Name: Wndy Atkinson
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Recruiting
- MGH
-
Principal Investigator:
- Elizabeth Gerstner
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with brain tumors or tumors affecting the brain.
Description
Inclusion Criteria:
- Brain Tumor
Exclusion Criteria:
- Unable to undergo MRI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with brain tumors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
patients alive and progression free at 6 months
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
January 11, 2013
First Submitted That Met QC Criteria
May 6, 2013
First Posted (Estimate)
May 7, 2013
Study Record Updates
Last Update Posted (Actual)
March 26, 2018
Last Update Submitted That Met QC Criteria
March 22, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012p001007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Tumors
-
University of FloridaCompletedCentral Nervous System TumorsUnited States
-
Children's Hospital Los AngelesUnknownBrain and Central Nervous System TumorsUnited States, Canada, Australia, Switzerland, New Zealand
-
St. Jude Children's Research HospitalCompletedBrain Tumors | Central Nervous System TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumors | Central Nervous System TumorsUnited States, Australia, Canada
-
Emory UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterTerminatedBrain Tumors | Central Nervous System TumorsUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsBrain and Central Nervous System TumorsUnited States
-
Children's Hospital Medical Center, CincinnatiTerminatedSolid Tumors | Brain TumorsUnited States
Clinical Trials on MRI scan
-
University of ChicagoRecruitingBreast CancerUnited States
-
Radboud University Medical CenterCompletedHead and Neck NeoplasmsNetherlands
-
Jeffrey A. Lieberman, MDTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
Amsterdam UMC, location VUmcMRIguidance B.V.CompletedSinusitis | Hearing Loss | Head and Neck Tumor | Cholesteatoma | Imaging of Bony Structures of the Head (Various Conditions)Netherlands
-
West China HospitalRecruiting
-
Imperial College LondonRecruitingDiastolic DysfunctionUnited Kingdom
-
The Clatterbridge Cancer Centre NHS Foundation...Unknown
-
University of OxfordRecruiting
-
University of AberdeenNHS GrampianRecruiting